Reuters logo
a month ago
BRIEF-Clearside Biomedical announces first patient randomized in phase 2 clinical trial of CLS-TA
July 11, 2017 / 8:58 PM / a month ago

BRIEF-Clearside Biomedical announces first patient randomized in phase 2 clinical trial of CLS-TA

July 11 (Reuters) - Clearside Biomedical Inc

* Clearside Biomedical announces first patient randomized in phase 2 clinical trial of cls-ta used together with eylea in patients with diabetic macular edema

* Clearside Biomedical Inc - currently expect to report three-month preliminary data in first half of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below